(Q38456151)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936847%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

review article

1 reference

title

Parkinson's disease: a review of non-motor symptoms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936847%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936847%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Abdul Qayyum Rana

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936847%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Zishan M Chaudry

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936847%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Sai Vasan

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936847%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

1 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936847%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936847%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936847%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936847%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

549-562

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25936847%20AND%20SRC:MED&resulttype=core&format=json

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease.

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Non-motor symptoms of Parkinson's disease: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

What contributes to quality of life in patients with Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Depression in Parkinson's disease -- a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Stress, depression and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Treatment of depressive symptoms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Update on the use of pramipexole in the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Psychosis, apathy, depression and anxiety in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Anxiety in Parkinson's disease: identification and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Non-recognition of depression and other non-motor symptoms in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Characteristics of apathy in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Syndromic validity of apathy in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Apathy and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Apathy in Parkinson's disease: diagnosis, neuropsychological correlates, pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Genetics of impulse control disorders in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Impulse control disorders in Parkinson's disease: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Zonisamide in managing impulse control disorders in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Functional neuroimaging in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Mild cognitive impairment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Cognitive profile of patients with newly diagnosed Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Neurodegeneration across stages of cognitive decline in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Metabolic brain networks associated with cognitive function in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Executive dysfunction in Parkinson's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Daytime sleepiness in elderly Parkinson's disease patients and treatment with the psychostimulant modafinil: A preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

The pathomechanisms underlying Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Circadian and sleep disorders in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Treatment of restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Association of pain, Parkinson's disease, and restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Long-term use of pramipexole in the management of restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Behavioral therapy to treat urinary incontinence in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Prevalence of bladder dysfunction in Parkinsons disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

The risk of bladder and autonomic dysfunction in a community cohort of Parkinson's disease patients and normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Pathophysiology of bradykinesia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Sexual function in patients with Parkinson's disease and their partners

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Management of sexual dysfunction in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Diagnosis, assessment, and treatment of hypersexuality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Effect of subthalamic deep brain stimulation on non-motor fluctuations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Nonmotor fluctuations in Parkinson's disease: clinical spectrum and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Pain in Parkinson's disease: analysis and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Olfactory dysfunction in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Parkinson's disease: clinical features and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Olfactory loss in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Pathological correlates of gastrointestinal dysfunction in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

The management of gastrointestinal symptoms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Dysphagia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Musculoskeletal problems in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Scoliosis in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

Postural deformities in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244

'The clocks that time us'--circadian rhythms in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2015.1038244